Key Takeaways

  • Federal research productivity has dropped roughly 80-fold since 1950, halving every nine years despite the NIH budget swelling to $47 billion.
  • An analysis led by Senator Ted Cruz found that approximately 25% of National Science Foundation grants during the Biden administration, totaling $8 billion over four years, went toward DEI-related criteria.
  • The White House Office of Science and Technology Policy is creating dedicated meta-science units at both the NSF and NIH to run live experiments on grant distribution.
  • Federal grant boards will pilot The Golden Ticket Grant Review Model to bypass consensus committee filters and back unconventional research.

The Golden Ticket Grant Review Model

Traditional peer-review panels kill high-variance ideas because committees naturally converge on the safest middle ground. To break that bottleneck, the administration is testing a direct selection process across federal research agencies.

  • Step 1: Allocate Unilateral Selection Tickets: Each peer-review evaluator is given one to three golden tickets to allocate independently rather than relying solely on standard merit-review committee consensus.
  • Step 2: Unilateral Grant Approval: The reviewer uses a golden ticket to unilaterally select and approve a grant application without requiring agreement or compromise from the rest of the review committee.
  • Step 3: Incentivize High-Risk, Non-Consensus Proposals: Scientists are encouraged to submit bold, out-of-the-box research proposals rather than safe, consensus-driven ideas designed merely to satisfy standard review boards.
  • Step 4: Meta-Science Tracking and Course Correction: Meta-science units at agencies like the NSF analyze the resulting breakthrough rates and course-correct funding streams based on measured scientific return.

When This Works (and When It Doesn't)

This review method works when traditional grant committees default to low-risk consensus proposals that stifle scientific breakthroughs. As Michael Kratsios explained, “The reviewer will then be able to unilaterally without the rest of the committee agreeing can make a selection of a particular grant. So, you incentivize folks to have more interesting grants.”

It fails when applied to administrative compliance checks or safety reviews where broad consensus is necessary. If a project carries severe biosafety or regulatory risks, bypassing committee review creates blind spots. But for pure discovery and early-stage hypothesis testing, consensus is the enemy of outliers. As David Friedberg noted regarding Eroom's Law, research efficiency “has fallen roughly 80fold since 1950 in terms of outcomes per dollar spent. And it halves every 9 years. So every 9 years we get half as efficient as we were at getting a return on the investment we're making.” When the baseline return collapses that fast, running controlled funding experiments is the only way out.

What to Do With This

If you run an internal R&D team, product review board, or seed investment committee, consensus voting is quietly killing your best bets. Implement golden tickets in your next quarterly planning cycle.

First, give each team lead one unilateral pass per quarter. That pass lets them greenlight a single experimental feature or technical sprint without needing approval from product management or executive leadership. Second, require the creator to pitch an extreme hypothesis rather than an incremental fix. Third, track the output separately after six months. If your consensus bets and your unilateral bets produce the same hit rate, your team is playing too safe on both sides.